Search Results

You are looking at 1 - 10 of 165 items for :

  • All content x
Clear All
Open access

Jie Shi, Zhen Yang, Yixin Niu, Weiwei Zhang, Ning Lin, Xiaoyong Li, Hongmei Zhang, Hongxia Gu, Jie Wen, Guang Ning, Li Qin, and Qing Su

an automated electronic device (OMRON Model1 Plus; Omron Company, Kyoto, Japan) after the subjects sat down and rested quietly for >5 min. BP measurements were taken three times and the mean was recorded as the BP result. Overweight was defined as 24

Open access

Volha V Zhukouskaya, Anya Rothenbuhler, Annamaria Colao, Carolina Di Somma, Peter Kamenický, Séverine Trabado, Dominique Prié, Christelle Audrain, Anna Barosi, Christèle Kyheng, Anne-Sophie Lambert, and Agnès Linglart

level and BMI. On the other hand, phosphorus supplementation for 3 months significantly decreased body weight, BMI, waist circumference; restored diet-induced thermogenesis; and increased post-prandial satiety in obese/overweight subjects ( 10 , 11

Open access

Fang Lv, Xiaoling Cai, Chu Lin, Tianpei Hong, Xiaomei Zhang, Zhufeng Wang, Huifang Xing, Guizhi Zong, Juming Lu, Xiaohui Guo, Jing Wu, Leili Gao, Xianghai Zhou, Xueyao Han, and Linong Ji

Introduction It was well-known that the prevalence of overweight and obesity is increasing worldwide. It was reported that 39% of adults aged more than 18 years were overweight, and about 13% of the world’s adult population were obese in 2016

Open access

Charlotte Janus, Dorte Vistisen, Hanan Amadid, Daniel R Witte, Torsten Lauritzen, Søren Brage, Anne-Louise Bjerregaard, Torben Hansen, Jens J Holst, Marit E Jørgensen, Oluf Pedersen, Kristine Færch, and Signe S Torekov

responsible for up to 70% of the postprandial insulin response in healthy individuals whilst being severely impaired in patients with prediabetes and T2D ( 5 , 6 ). Furthermore, GLP-1 responses are lower in individuals with overweight and obesity

Open access

Mirjam M Oosterwerff, Rosa Meijnen, Natasja M Van Schoor, Dirk L Knol, Mark H H Kramer, Mireille N M Van Poppel, Paul Lips, and E Marelise W Eekhoff

Introduction Physical inactivity has been identified as the fourth leading risk factor for global mortality, while overweight and obesity are in the fifth place (1) . Both factors are more prevalent among non-western immigrants in The Netherlands

Open access

Mojca Jensterle, Nika Aleksandra Kravos, Simona Ferjan, Katja Goricar, Vita Dolzan, and Andrej Janez

in overweight-obese patients with PCOS and normal baseline glycemic homeostasis on body mass (BM), menstrual frequencies (MF), metabolic and hormonal outcomes. This allows us to summarize our perspective in future research that can help to identify

Open access

Zeeshan Javed, Maria Papageorgiou, Leigh A Madden, Alan S Rigby, Eric S Kilpatrick, Stephen L Atkin, and Thozhukat Sathyapalan

stiffness and vascular resistance and decrease the relative risk for cardiovascular and all-cause mortality in patients with type 2 diabetes ( 27 , 28 ). In the first study comparing the effects of empagliflozin and metformin in overweight/obese women with

Open access

Lars Peter Sørensen, Tina Parkner, Esben Søndergaard, Bo Martin Bibby, Holger Jon Møller, and Søren Nielsen

demonstrated that expansion of visceral adipose tissue (VAT) rather than subcutaneous adipose tissue (SAT) depots is critical for the development of obesity-associated insulin resistance, and that, at least in overweight/obese subjects, expansion of SAT depots

Open access

S U Jayasinghe, S J Torres, C A Nowson, A J Tilbrook, and A I Turner

baseline resting period and low frequency of sampling. Furthermore, very little research has considered the SAM system and the HPA axis together. The aims of this study were to determine whether lean and overweight/obese men differ in their cortisol and

Open access

Jing Wang, Leishen Wang, Huikun Liu, Shuang Zhang, Junhong Leng, Weiqin Li, Tao Zhang, Nan Li, Wei Li, Andrea A Baccarelli, Lifang Hou, and Gang Hu

, two recent studies from the Hyperglycemia and Adverse Pregnancy Outcome study (HAPO) ( 10 ) and Kaiser Permanente Northwest and Hawaii ( 11 ) presented that maternal hyperglycemia during pregnancy increased the offspring’s risk of overweight and